Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersPediatric Infectious Diseases Physician in Los Angeles, CA
NPI: 1750301503Primary Practice Location
RONALD REAGAN UCLA MEDICAL CENTER
757 Westwood Plz, Los Angeles, CA
Primary Employer
UCLA Dept of Pediatric Grp Practice
uclahealth.org
HQ Phone
Get M.D. Jaime's Phone Numberphone_androidMobile
Get M.D. Jaime's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
1992 - 2026
NC State Medical License
1987 - 1999
CA State Medical License
American Board of Pediatrics
Pediatrics
American Board of Pediatrics
Pediatric Infectious Diseases
Los Angeles County-Harbor-UCLA Medical Center
Fellowship • Pediatric Infectious Diseases
1993 - 1996
SUNY Downstate Health Sciences University
downstate.edu
Residency • Pediatrics
1988 - 1992
Cayetano Heredia University
Medical School
Until 1985
Ciprofloxacin-resistant Aeromonas hydrophila cellulitis following leech therapy
Authors: Patricia Flynn, Dwight Yin, Ann Buchanan
Journal: Lancet HIV
Authors: Karin Nielsen
Journal: J Clin Microbiol
Lead Sponsor: ViiV Healthcare
Intervention / Treatment: DRUG: Dolutegravir film-coated tablets, DRUG: Dolutegravir film-coated dispersible tablets, DRUG: ABC/DTG/3TC immediate release tablets, DRUG: ABC/DTG/3TC film-coated dispersible tablets
Lead Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Collaborators: National Institute of Mental Health (NIMH), National Institute of Allergy and Infectious Diseases (NIAID), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Intervention / Treatment: OTHER: Cohort 1
Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators: Gilead Sciences
Intervention / Treatment: DRUG: Remdesivir
